Advertisement

Advertisement

HK:2185 Stock Latest News

Shanghai Bio-Heart Narrows Loss as Iberis RDN Launch Drives First Revenue

Company AnnouncementsShanghai Bio-Heart Narrows Loss as Iberis RDN Launch Drives First Revenue

Shanghai Bio-Heart Secures Thailand Registration for Iberis Renal Denervation System

PremiumCompany Announcements

Shanghai Bio-Heart Secures Thailand Registration for Iberis Renal Denervation System

20d ago

Shanghai Bio-Heart Schedules Board Meeting to Approve 2025 Results and Consider Final Dividend

PremiumCompany Announcements

Shanghai Bio-Heart Schedules Board Meeting to Approve 2025 Results and Consider Final Dividend

21d ago

Shanghai Bio-Heart’s Iberis Renal Denervation System Registered in Indonesia

PremiumCompany Announcements

Shanghai Bio-Heart’s Iberis Renal Denervation System Registered in Indonesia

2M ago

Shanghai Bio-heart Registers Iberis® RDN System in New Zealand

PremiumCompany Announcements

Shanghai Bio-heart Registers Iberis® RDN System in New Zealand

4M ago

Shanghai Bio-heart’s Iberis® RDN System Gains UK Registration

PremiumCompany AnnouncementsShanghai Bio-heart’s Iberis® RDN System Gains UK Registration

5M ago

Shanghai Bio-heart Achieves Milestone with First Iberis® RDN System Procedure in Switzerland

Company Announcements

Shanghai Bio-heart Achieves Milestone with First Iberis® RDN System Procedure in Switzerland

6M ago

Shanghai Bio-heart’s Controlling Shareholder to Boost Stake

Company Announcements

Shanghai Bio-heart’s Controlling Shareholder to Boost Stake

6M ago

Shanghai Bio-Heart Reports Revenue Surge with Iberis® System Launch

PremiumCompany Announcements

Shanghai Bio-Heart Reports Revenue Surge with Iberis® System Launch

7M ago

Shanghai Bio-heart Schedules Board Meeting to Review Interim Results

PremiumCompany Announcements

Shanghai Bio-heart Schedules Board Meeting to Review Interim Results

8M ago

Shanghai Bio-heart Completes H Share Repurchase and Capital Reduction

PremiumCompany Announcements

Shanghai Bio-heart Completes H Share Repurchase and Capital Reduction

8M ago

Shanghai Bio-heart Approves Key Resolutions at 2024 AGM

PremiumCompany Announcements

Shanghai Bio-heart Approves Key Resolutions at 2024 AGM

10M ago

Shanghai Bio-heart Announces Waiver for Share Buy-back Proposal

PremiumCompany AnnouncementsShanghai Bio-heart Announces Waiver for Share Buy-back Proposal

10M ago

Shanghai Bio-heart Biological Technology Announces 2024 AGM and Strategic Resolutions

Company Announcements

Shanghai Bio-heart Biological Technology Announces 2024 AGM and Strategic Resolutions

10M ago

Shanghai Bio-Heart Ends 2022 H Share Incentive Scheme and Plans Share Repurchase

Company Announcements

Shanghai Bio-Heart Ends 2022 H Share Incentive Scheme and Plans Share Repurchase

11M ago

Shanghai Bio-heart Launches Clinical Trial for Sirolimus DCB in Japan

PremiumCompany Announcements

Shanghai Bio-heart Launches Clinical Trial for Sirolimus DCB in Japan

1y ago

Shanghai Bio-Heart Reports Reduced Losses and Key Milestones in 2024

PremiumCompany Announcements

Shanghai Bio-Heart Reports Reduced Losses and Key Milestones in 2024

1y ago

Shanghai Bio-Heart Announces Board Composition and Roles

PremiumCompany Announcements

Shanghai Bio-Heart Announces Board Composition and Roles

1y ago

Shanghai Bio-Heart Forms Nomination Committee to Enhance Board Governance

PremiumCompany Announcements

Shanghai Bio-Heart Forms Nomination Committee to Enhance Board Governance

1y ago

Shanghai Bio-heart Schedules Board Meeting to Review Annual Results

PremiumCompany AnnouncementsShanghai Bio-heart Schedules Board Meeting to Review Annual Results

1y ago

Shanghai Bio-Heart Launches Iberis® RDN System in Europe

Company Announcements

Shanghai Bio-Heart Launches Iberis® RDN System in Europe

1y ago

Shanghai Bio-heart’s Iberis® RDN System Gains NMPA Approval

Company Announcements

Shanghai Bio-heart’s Iberis® RDN System Gains NMPA Approval

1y ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >